Cargando…
Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis
Latent membrane protein 1 (LMP1) is identified as the main transforming oncoprotein of Epstein-Barr virus (EBV). LMP1 is frequently expressed in a variety of EBV-associated cancers, including nasopharyngeal carcinoma (NPC), non-Hodgkin lymphoma (NHL), Hodgkin disease (HD), and gastric cancer (GC). H...
Autores principales: | Chen, Yu-Pei, Zhang, Wen-Na, Chen, Lei, Tang, Ling-Long, Mao, Yan-Ping, Li, Wen-Fei, Liu, Xu, Zhou, Guan-Qun, Sun, Ying, Kang, Tie-Bang, Zeng, Mu-Sheng, Liu, Na, Ma, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745728/ https://www.ncbi.nlm.nih.gov/pubmed/26336130 |
Ejemplares similares
-
Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015) -
Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma
por: Yu, Ping-Hung, et al.
Publicado: (2013) -
Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021) -
Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023) -
A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy
por: Cho, Hyun-Il, et al.
Publicado: (2018)